SIGN UP
LOG IN
U
UPC
Universe Pharmaceuticals Inc
4.88
0.10+2.09%After Hours: 4.700 -0.18 -3.69%19:55 05/01 EDT
OPEN/PREV CLOSE5.11/4.780
TODAY RANGE4.720-5.14
VOL68.19K
MARKET CAP2.75M
52 WEEK RANGE2.510-2,592.00
AVG VOL (3M)550.81K
% TURNOVER12.11%
TURNOVER--
P/E (TTM)-0.0638
% RANGE8.79%
EPS(TTM)-76.4384
P/E(FORWARD)--
P/B0.0444
BVPS110.02
DIVIDEND--
P/S0.0365
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.73M
SHARES OUTSTANDING563.34K
NEXT EARNINGS--
FREE FLOAT559.87K
LOT SIZE1
EX-DIV DATE03/24/2025
News
Press Releases
Financial Reports
Profile
Benzinga·2d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·2d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga·04/22 12:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga·04/21 21:05
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga·04/16 17:06
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·04/16 12:07
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·04/04 17:06
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·04/01 17:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
TipRanks·03/21 23:50
Universe Pharmaceuticals Inc trading halted, news pending
Seeking Alpha·03/20 12:42
Universe Pharmaceuticals to conduct share consolidation
Benzinga·03/14 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
TipRanks·03/03 21:33
Universe Pharmaceuticals Adjourns Shareholder Meeting Due to Lack of Quorum
Seeking Alpha·02/25 21:32
Universe Pharmaceuticals receives notice from Nasdaq related to delayed annual report
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.